Gilead
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
835 Market St Ste 800, San Francisco, Ca...Website
www.gileadchina.cnRevenue
$10.9 MillionIndustry
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for life-threatening diseases. The company focuses on virology, oncology, and inflammatory diseases, providing treatments for HIV, hepatitis B, hepatitis C, and COVID-19. Through its subsidiary Kite, it also develops cell therapies for various types of cancer. Additionally, the company researches next-generation therapies for fibrotic and inflammatory conditions such as lupus, inflammatory bowel disease, and primary biliary cholangitis. Gilead serves patients and healthcare providers globally, delivering its value through a portfolio of approved medicines and a research pipeline aimed at addressing unmet medical needs.Explore more
Gilead Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Gilead
Compare insights from companies similar to Gilead, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Gilead Tech Stack
A closer look at the technologies used by Gilead
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gilead
Sign Up For FreeTo access detailed company insights
Gilead Sciences is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for life-threatening diseases. The company focuses on virology, oncology, and inflammatory diseases, providing treatments for HIV, hepatitis B, hepatitis C, and COVID-19. Through its subsidiary Kite, it also develops cell therapies for various... Read More
